blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2473521

EP2473521 - B7-H4 FUSION PROTEINS AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.12.2016
Database last updated on 24.08.2024
Most recent event   Tooltip16.12.2016Application deemed to be withdrawnpublished on 18.01.2017  [2017/03]
Applicant(s)For all designated states
MedImmune, LLC
One MedImmune Way
Gaithersburg, MD 20878 / US
[2015/50]
Former [2015/45]For all designated states
Medimmune, LLC
One Medimmune Way
Gaithersburg, Maryland 20878 / US
Former [2012/28]For all designated states
Amplimmune, Inc.
45 W. Watkins Mill Road
Suite A
Gaithersburg, MD 20878 / US
Inventor(s)01 / LANGERMANN, Solomon
6606 Cross Country Boulevard
Baltimore, MD 21215 / US
02 / LIU, Linda
6512 Tipperary Court
Clarkesville, MD 21029 / US
03 / PODOJIL, Joseph, R.
4533 Saratoga Avenue
Downers Grove, IL 60515 / US
04 / MILLER, Stephen, D.
946 Gunderson Avenue
Oak Park, IL 60304 / US
05 / MARSHALL, Shannon
1503 Frederick Road
Baltimore, MD 21228 / US
 [2012/28]
Representative(s)Walker, Ross Thomson
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
[N/P]
Former [2012/28]Walker, Ross Thomson
Forresters
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Application number, filing date10748218.431.08.2010
WO2010US47366
Priority number, dateUS20090238605P31.08.2009         Original published format: US 238605 P
US20090254930P26.10.2009         Original published format: US 254930 P
US20090266854P04.12.2009         Original published format: US 266854 P
US20090286537P15.12.2009         Original published format: US 286537 P
US20100378361P30.08.2010         Original published format: US 378361 P
[2012/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011026122
Date:03.03.2011
Language:EN
[2011/09]
Type: A2 Application without search report 
No.:EP2473521
Date:11.07.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 03.03.2011 takes the place of the publication of the European patent application.
[2012/28]
Search report(s)International search report - published on:EP28.04.2011
ClassificationIPC:C07K14/705, C07K16/28, G01N33/68, G01N33/564, G01N33/50, A61K38/17, A61K47/48
[2012/28]
CPC:
C07K14/70532 (EP,US); A61K38/1709 (US); A61K39/44 (US);
A61K9/0019 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P11/00 (EP); A61P13/12 (EP); A61P17/06 (EP);
A61P17/14 (EP); A61P19/02 (EP); A61P21/00 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P41/00 (EP);
A61P43/00 (EP); A61P5/14 (EP); A61P7/00 (EP);
A61P7/06 (EP); A61P9/00 (EP); C07K16/2827 (US);
G01N33/6863 (EP,US); G01N33/6866 (EP,US); G01N33/6869 (EP,US);
A61K38/00 (EP,US); C07K2317/50 (US); C07K2317/56 (US);
C07K2317/72 (EP,US); C07K2319/30 (US); C07K2319/32 (EP,US);
G01N2800/52 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/28]
TitleGerman:B7-H4-FUSIONSPROTEINE UND IHRE VERWENDUNG[2012/28]
English:B7-H4 FUSION PROTEINS AND METHODS OF USE THEREOF[2012/28]
French:PROTÉINES DE FUSION B7-H4 ET LEURS PROCÉDÉS D'UTILISATION[2012/28]
Entry into regional phase19.03.2012National basic fee paid 
19.03.2012Designation fee(s) paid 
19.03.2012Examination fee paid 
Examination procedure19.03.2012Examination requested  [2012/28]
19.10.2012Amendment by applicant (claims and/or description)
09.01.2015Despatch of a communication from the examining division (Time limit: M04)
19.05.2015Reply to a communication from the examining division
07.04.2016Despatch of a communication from the examining division (Time limit: M04)
18.08.2016Application deemed to be withdrawn, date of legal effect  [2017/03]
13.09.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/03]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.01.2015
Fees paidRenewal fee
10.08.2012Renewal fee patent year 03
26.08.2013Renewal fee patent year 04
28.08.2014Renewal fee patent year 05
27.08.2015Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.08.201607   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]US2009142342  (CHEN LIEPING [US]) [X] 1-24,29,30 * the whole document * * paragraphs [0075] - [0089]; sequences 1-38 * * paragraphs [0012] - [0015] - [0022] , [0037] - [0041] - [0054] - [0091] - [0096] , [0118] - [0120] - [0144] - [0157]; figures 1,8a; claims 1-16 * * paragraphs [0025] , [0028] , [0188] - [0204] * [I] 25-28;
 [XI]US2008160036  (CHEN LIEPING [US]) [X] 1-24,29,30 * the whole document * * paragraphs [0040] - [0044] - [0049] , [0063] - [0074] - [0106] - [0124]; claims 1-21; sequence SEQ ID NO 2 * [I] 25-28;
 [Y]WO2004113500  (UNIV WASHINGTON [US], et al) [Y] 1-30 * sequence 2 * * the whole document * * paragraphs [0132] - [0134] - [0158]; example 2; claims 1-54 *;
 [Y]WO2006124667  (ZYMOGENETICS INC [US], et al) [Y] 1-30 * the whole document * * paragraphs [0014] , [0015] , [0018] , [0328] , [0329] , [0409] , [0414] , [0415] , [0420] - [0425]; claims 1-77 *;
 [Y]WO2007067681  (UNIV LOUISVILLE RES FOUND [US], et al) [Y] 1-30 * the whole document * * paragraphs [0009] - [0026]; claims 1-20 *;
 [Y]WO0210187  (MAYO FOUNDATION [US], et al) [Y] 1-30 * the whole document * * pages 1-9 * * pages 12-15,21 * * pages 37,38; example 6; claims 34-52 *;
 [Y]US2009011444  (CHEN LIEPING [US]) [Y] 1-30 * the whole document *;
 [Y]WO2006101487  (UNIV THE BOARD OF TRUSTEES OF [US], et al) [Y] 23-30 * the whole document *;
 [Y]US2004180047  (CHEN LIEPING [US], et al) [Y] 23-30 * paragraphs [0148] , [0180] *;
 [Y]US2009124573  (MAZMANIAN SARKIS [US], et al) [Y] 23-30 * the whole document *;
 [Y]US2008159998  (ICHIM THOMAS E [US]) [Y] 23-30 * the whole document *
    [ ] - "Human B7-H4 protein IgV domain, SEQ ID 37.", Geneseq, (20090709), Database accession no. AWW37859, URL: EBI [ ] * sequence 37 *
    [ ] - "Human B7-H4 protein IgV domain, SEQ ID 38.", Geneseq, (20090709), Database accession no. AWW37860, URL: EBI [ ] * sequence 38 *
by applicantUS6982323
 US5821333
 US5932448
 US5283173
 US6562576
 WO0100814
 US6790624
 WO2008147482
 WO2004084933
 WO9522972
 WO9516691
 WO9504738
 US6015809
 US5989591
 US5567709
 US5559112
 US5530006
 US5484790
 US5385908
 US5202332
 US5162333
 US5780462
 US5120727
 WO0001385
 WO2009005352
    - LENSHOW ET AL., ANNU. REV. IMMUNOL., (1996), vol. 14, pages 233 - 258
    - CHAMBERS; ALLISON, CURR. OPIN. IMMUNOL., (1997), vol. 9, pages 396 - 404
    - RATHMELL; THOMPSON, ANNU. REV. IMMUNOL., (1999), vol. 17, pages 781 - 828
    - KRUMMEL; ALLISON, J. EXP. MED, (1996), vol. 183, pages 2533 - 2540
    - WALUNAS ET AL., J EXP. MED, (1996), vol. 183, pages 2541 - 2550
    - DONG ET AL., NATURE MED, (1999), vol. 5, pages 1365 - 1369
    - FREEMAN ET AL., J EXP. MED, (2000), vol. 192, pages 1 - 9
    - TSENG ET AL., J. EXP. MED, (2001), vol. 193, pages 839 - 846
    - LATCHMAN ET AL., NATURE IMMUNOL., (2001), vol. 2, pages 261 - 268
    - WANG ET AL., BLOOD, (2000), vol. 96, pages 2808 - 2813
    - SWALLOW ET AL., IMMUNITY, (1999), vol. 11, pages 423 - 432
    - YOSHINAGA ET AL., NATURE, (1999), vol. 402, pages 827 - 832
    - CHAPOVAL ET AL., NATURE IMMUNOL., (2001), vol. 2, pages 269 - 274
    - CHOI ET AL., J IMMUNOL., (2003), vol. 171, pages 4650 - 4654
    - SICA ET AL., IMMUNITY, (2003), vol. 18, pages 849 - 861
    - PRASAD ET AL., IMMUNITY, (2003), vol. 18, pages 863 - 873
    - ZANG ET AL., PROC. NATL. ACAD SCI. US A., (2003), vol. 100, pages 10388 - 10392
    - DONG ET AL., IMMUNOL. RES., (2003), vol. 28, pages 39 - 48
    - KRYCZEK, J.I., J. IMMUNOL., (2006), vol. 177, no. 1, pages 40 - 44
    - CHEN, Y., KIDNEY INT., (20061018), vol. 70, no. 12, pages 2092 - 9
    - SUH. W.K. ET AL., MOL CELL BIOL., (2006), vol. 26, no. 17, pages 6403 - 11
    - ZHU, G. ET AL., BLOOD, (20081224), vol. 113, no. 8, pages 1759 - 67
    - CHAPOVAL ET AL., METHODS MOL. MED, (2000), vol. 45, pages 247 - 255
    - MUELLER ET AL., MOL. IMMUN., (1997), vol. 34, no. 6, pages 441 - 452
    - SWANN ET AL., CUR. OPIN. IMMUN., (2008), vol. 20, pages 493 - 499
    - PRESTA, CUR. OPIN. LMMUN., (2008), vol. 20, pages 460 - 470
    - ANGAL, S. ET AL., MOLECULAR IMMUNOLOGY, (1993), vol. 30, no. 1, pages 105 - 108
    - MUELLER, J. ET AL., MOLECULAR IMMONOLOGY, (1997), vol. 34, no. 6, pages 441 - 452
    - STAVENHAGEN ET AL., CANCER RES., (2007), vol. 57, no. 18, pages 8882 - 90
    - VIDAL ET AL., BIOCHEMISTRY, (2004), vol. 43, pages 7336 - 44
    - ZHOU ET AL., NATURE, (1995), vol. 378, pages 584 - 592
    - SUDOL, PROG. BIOCHYS. MOL. BIO., (1996), vol. 65, pages 113 - 132
    - KIM ET AL., NATURE, (1995), vol. 378, pages 85 - 88
    - KOMAU ET AL., SCIENCE, (1995), vol. 269, pages 1737 - 1740
    - HU ET AL., JBIOL CHEM., (1998), vol. 273, pages 33489 - 33494
    - ARAKAWA ET AL., J BIOL. CHEM., (1994), vol. 269, no. 45, pages 27833 - 27839
    - RADZIEJEWSKI ET AL., BIOCHEM., (1993), vol. 32, no. 48, page 1350
    - KATAHIRA ET AL., J. BIOL. CHEM., (2002), vol. 277, pages 9242 - 9246
    - GUO, EMBO J., (1998), vol. 17, pages 5265 - 5272
    - MALASHKEVICH ET AL., SCIENCE, (1996), vol. 274, pages 761 - 765
    - SUMMERTON; WELLER, ANTISENSE NUCLEIC ACID DRUG DEV., (1997), vol. 7, pages 187 - 195
    - HYRUP ET AL., BIOORGAN. MED. CHEM., (1996), vol. 4, pages 5 - 23
    - MATHIOWITZ; LANGER, J. CONTROLLED RELEASE, (1987), vol. 5, pages 13 - 22
    - MATHIOWITZ ET AL., REACTIVE POLYMERS, (1987), vol. 6, pages 275 - 283
    - MATHIOWITZ ET AL., J. APPL. POLYMER SCI., (1988), vol. 35, pages 755 - 774
    - WONG ET AL., SCIENCE, (1985), vol. 228, pages 810 - 815
    - LEWIS, GENETIC ENGINEERING NEWS, (1992), vol. 12, page 1
    - GUATELLI ET AL., PROC. NATL. ACAD SCI. USA, (1990), vol. 87, pages 1874 - 1878
    - WEISS, SCIENCE, (1991), vol. 254, pages 1292 - 1293
    - MONNEAUX, F. ET AL., ARTHRITIS & RHEUMATISM, (2002), vol. 46, no. 6, pages 1430 - 1438
    - ZHU,G. ET AL., BLOOD, (2009), vol. 113, pages 1759 - 1767
    - AZUMA, T. ET AL., PLOS. MED, (2009), vol. 6, page E1000166
    - CHEN ET AL., PNAS, (2006), vol. 103, no. 44, pages 16400 - 16405
    - KATZ ET AL., CELL, (1993), vol. 74, no. 6, pages 1089 - 100
    - DAIKH; WOFSY, J IMMUNOL., (2001), vol. 166, no. 5, pages 2913 - 6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.